Next Article in Journal
Nanostructured Lipid Carrier-Based Codelivery of Raloxifene and Naringin: Formulation, Optimization, In Vitro, Ex Vivo, In Vivo Assessment, and Acute Toxicity Studies
Next Article in Special Issue
Employ of Anthocyanins in Nanocarriers for Nano Delivery: In Vitro and In Vivo Experimental Approaches for Chronic Diseases
Previous Article in Journal
Computation-Aided Design of Albumin Affibody-Inserted Antibody Fragment for the Prolonged Serum Half-Life
Previous Article in Special Issue
Investigations on Cellular Uptake Mechanisms and Immunogenicity Profile of Novel Bio-Hybrid Nanovesicles
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(9), 1770; https://doi.org/10.3390/pharmaceutics14091770
Action Date Notes Link
article xml file uploaded 24 August 2022 16:32 CEST Original file -
article xml uploaded. 24 August 2022 16:32 CEST Update https://www.mdpi.com/1999-4923/14/9/1770/xml
article pdf uploaded. 24 August 2022 16:32 CEST Version of Record https://www.mdpi.com/1999-4923/14/9/1770/pdf
article supplementary file uploaded. 24 August 2022 16:32 CEST - https://www.mdpi.com/1999-4923/14/9/1770#supplementary
article html file updated 24 August 2022 16:33 CEST Original file -
article html file updated 24 August 2022 21:42 CEST Update https://www.mdpi.com/1999-4923/14/9/1770/html
Back to TopTop